BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23704232)

  • 21. Value of cancer care: ethical considerations for the practicing oncologist.
    Jagsi R; Sulmasy DP; Moy B
    Am Soc Clin Oncol Educ Book; 2014; ():e146-9. PubMed ID: 24857095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient Centeredness and Engagement in Quality-of-Care Oncology Research.
    Clauser SB; Gayer C; Murphy E; Majhail NS; Baker KS
    J Oncol Pract; 2015 May; 11(3):176-9. PubMed ID: 25852140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does value mean quality? The payer's perspective.
    Malin JL
    J Oncol Pract; 2013 May; 9(3):116-8. PubMed ID: 23942484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer programs develop own guidelines to measure quality.
    Printz C
    Cancer; 2015 Feb; 121(4):488. PubMed ID: 25651984
    [No Abstract]   [Full Text] [Related]  

  • 25. NCCN's value pathways: the drive for quality cancer care.
    Goldsmith PJ
    J Natl Compr Canc Netw; 2013 Feb; 11(2):119-20. PubMed ID: 23411377
    [No Abstract]   [Full Text] [Related]  

  • 26. [Workshop - economic governance mechanisms : for Hematology and Oncology].
    Strech D; Deh U; Schmitz S; Gürkan I; Ostermann H; Krause SW
    Oncol Res Treat; 2015; 38 Suppl 1():3-22. PubMed ID: 25676572
    [No Abstract]   [Full Text] [Related]  

  • 27. The Future of Cancer Care: Are We Ready For Personalized Value?
    de Souza JA; Kelly C; Nabhan C
    J Natl Compr Canc Netw; 2015 Aug; 13(8):1049-51. PubMed ID: 26285249
    [No Abstract]   [Full Text] [Related]  

  • 28. Balancing the Economics and Ethics of Personalised Oncology.
    Flaum N; Hall P; McCabe C
    Trends Cancer; 2018 Sep; 4(9):608-615. PubMed ID: 30149879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services.
    Cangialose CB; Blair AE; Borchardt JS; Ades TB; Bennett CL; Dickersin K; Gesme DH; Henderson IC; McGinnis LS; Mooney K; Mortenson LE; Sperduto P; Winkenwerder W; Ballard DJ
    Cancer; 2000 Jun; 88(12):2876-86. PubMed ID: 10870075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care.
    Carlson RW; Scavone JL; Koh WJ; McClure JS; Greer BE; Kumar R; McMillian NR; Anderson BO
    J Natl Compr Canc Netw; 2016 Aug; 14(8):961-9. PubMed ID: 27496112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in Measuring Cost and Value in Oncology: Making It Personal.
    Yu PP
    Value Health; 2016; 19(5):520-4. PubMed ID: 27565267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement.
    Engstrom PF; Bloom MG; Demetri GD; Febbo PG; Goeckeler W; Ladanyi M; Loy B; Murphy K; Nerenberg M; Papagni P; Robson M; Sweetman RW; Tunis S; Demartino J; Larsen JK;
    J Natl Compr Canc Netw; 2011 Dec; 9 Suppl 6():S1-16. PubMed ID: 22203777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Policy Challenges and Opportunities to Address Changing Paradigms in Cancer Care Delivery.
    Winckworth-Prejsnar K; McCanney J; Schatz AA; Smedley W; Platanias LC; Benitez CM; Newcomer LN; Fitzgerald CL; Carlson RW
    J Natl Compr Canc Netw; 2019 May; 17(5):424-431. PubMed ID: 31085764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rationing in German health care with particular consideration of oncology: view points of German stakeholders--a qualitative interview study].
    Lange J; Gönner C; Vollmann J; Rauprich O
    Gesundheitswesen; 2015 Jan; 77(1):8-15. PubMed ID: 24696371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Many mountains to climb.
    Hagland M
    Healthc Inform; 2011 Oct; 28(10):10-5. PubMed ID: 22046619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative.
    O'Grady MA; Gitelson E; Swaby RF; Goldstein LJ; Sein E; Keeley P; Miller B; Li T; Weinstein A; Cohen SJ
    J Natl Compr Canc Netw; 2007 Oct; 5(9):875-82. PubMed ID: 17977500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of the National Comprehensive Cancer Network (NCCN) Distress Screening Tool as a Guidepost for Telephonic Oncology Case Management.
    Swanson AJ; Castel LD; McKenna PA; Shen YA; Sagar B
    Prof Case Manag; 2019; 24(3):148-154. PubMed ID: 30946253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperative groups are not..
    Peters WP
    Arch Intern Med; 2008 Oct; 168(19):2172-3; author reply 2173-4. PubMed ID: 18955657
    [No Abstract]   [Full Text] [Related]  

  • 40. Defining Value of Cancer Therapeutics-A Health System Perspective.
    Leopold C; Peppercorn JM; Zafar SY; Wagner AK
    J Natl Cancer Inst; 2018 Jul; 110(7):699-703. PubMed ID: 29788313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.